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Human pluripotent stem cells (hPSCs), including human embryonic
stem cells and induced pluripotent stem cells, are promising for
numerous biomedical applications, such as cell replacement ther-
apies, tissue and whole-organ engineering, and high-throughput
pharmacology and toxicology screening. Each of these applica-
tions requires large numbers of cells of high quality; however, the
scalable expansion and differentiation of hPSCs, especially for
clinical utilization, remains a challenge. We report a simple, defined,
efficient, scalable, and good manufacturing practice-compatible
3D culture system for hPSC expansion and differentiation. It
employs a thermoresponsive hydrogel that combines easy ma-
nipulation and completely defined conditions, free of any
human- or animal-derived factors, and entailing only recombi-
nant protein factors. Under an optimized protocol, the 3D sys-
tem enables long-term, serial expansion of multiple hPSCs lines
with a high expansion rate (∼20-fold per 5-d passage, for a 1072-
fold expansion over 280 d), yield (∼2.0 × 107 cells per mL of
hydrogel), and purity (∼95% Oct4+), even with single-cell inoc-
ulation, all of which offer considerable advantages relative to
current approaches. Moreover, the system enabled 3D directed
differentiation of hPSCs into multiple lineages, including dopa-
minergic neuron progenitors with a yield of ∼8 × 107 dopami-
nergic progenitors per mL of hydrogel and ∼80-fold expansion
by the end of a 15-d derivation. This versatile system may be
useful at numerous scales, from basic biological investigation to
clinical development.
Human pluripotent stem cells (hPSCs), including humanembryonic stem cells (hESCs) (1) and induced pluripotent
stem cells (iPSCs) (2), have the capacities for indefinite in vitro
expansion and differentiation into all cell types within adults (3).
They therefore represent highly promising cell sources for nu-
merous biomedical applications, such as cell replacement ther-
apies (4, 5), tissue and organ engineering (6), and pharmacology
and toxicology screens (7, 8). However, these applications require
large numbers of cells of high quality (4, 6–8). For instance, ∼105
surviving dopaminergic (DA) neurons, ∼109 cardiomyocytes, or
∼109 beta cells are likely required to treat a patient with Par-
kinson disease (PD), myocardial infarction (MI), or type I di-
abetes, respectively (9). Additionally, far more cells are needed
initially because both in vitro cell culture yields and subsequent
in vivo survival of transplanted cells are typically very low. As
examples of the latter, only ∼6% of transplanted dopaminergic
neurons or ∼1% of injected cardiomyocytes reportedly survive in
rodent models several months after transplantation (10, 11).
Furthermore, there are large patient populations with degener-
ative diseases or organ failure (9), including over 1 million people
with PD, 1–2.5 million with type I diabetes, and ∼8 million with MI
in the United States alone (12). Large numbers of cells are also
necessary for applications such as tissue engineering, where for
example ∼1010 hepatocytes or cardiomyocytes would be required
for an artificial human liver or heart, respectively (6). Additionally,
∼1010 cells may be needed to screen a million-compound library
once (8), and advances in combinatorial chemistry, noncoding
RNAs, and investigations of complex signaling and transcriptional
networks have given rise to large libraries that can be screened
against many targets (13). Massive numbers of hPSCs may therefore
be needed to deliver on the biomedical promise of these stem cells.
In general, hPSCs require key biological signals from their
substrate, and from one another (14, 15), that promote cell
survival and rapid proliferation and that culture systems must
thus provide. Current 2D-based cell culture systems—which
suffer from inherent heterogeneity and limited scalability and
reproducibility—are emerging as a bottleneck for producing suf-
ficient numbers of high-quality cells for downstream applications
(9, 16). An attractive approach for scaling up production is to
move cell culture from 2D to 3D (9, 17), and accordingly several
3D suspension systems have been probed for hPSCs production:
cell aggregates (18–21), cells on microcarriers (22, 23), and cells
in alginate microencapsulates (24) (SI Appendix, Table S1). Al-
though these approaches have some attractive aspects, they also
highlight significant challenges for 3D hPSC culture (9) (SI Ap-
pendix, Table S1) including the following: (i) the use of com-
ponents from human or animal tissue (e.g., Matrigel, serum, and/
or albumin), which limit reproducibility and/or scalability, pose
risks for pathogen and immunogen transfer (18–24), and are
thus problematic for good manufacturing practice (GMP) cell
production (25); (ii) substantial cell agglomeration that can in
some cases lead to differentiation and/or death (22, 23); (iii)
shear forces in agitated cultures that can compromise cell vi-
ability (18–23); (iv) limited cell expansion rates and cell yields
per volume (18–24); and (v) unclear potential for long-term
serial expansion. As an example, in a recent culture of hPSCs
within alginate hydrogel microspheres in mouse embryonic fibro-
blast conditioned medium, 5% of the encapsulated single hPSCs
remained viable after 7 d, and an ∼10- to 20-fold expansion to
a peak density of 3 × 106 cells per mL occurred after 20 d (24).
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To address these challenges, we report an alternative system
that expands and differentiates hPSCs within a thermorever-
sible hydrogel, composed of a polymeric solution that is liquid
at low temperature but solidifies into an elastic hydrogel when
warmed. Cells can thus be mixed with the liquid at low tem-
perature, suspended and grown in a solid gel at 37 °C, and
harvested and passaged by reliquifying the gel at low temper-
ature. The resulting hydrogel offers many features that benefit
hPSC biology and culture, including a 3D environment for
rapid cell growth, prevention of large cell aggregate formation,
isolation of cells from shear forces, and sufficient porosity for
nutrient diffusion. Although thermoreversible materials have
been used for culturing primary cells in the laboratory (26), large-
scale hPSC culture presents numerous additional challenges and
constraints, including apoptosis upon cell dissociation (14) and
passaging; low survival, limited proliferation, and loss of pluri-
potency in suboptimal culture conditions; and a strong prefer-
ence for defined medium to support downstream biomedical
applications. We have accordingly investigated these challenges
and developed a chemically defined system with no matrix pro-
teins that is capable of 1072-fold expansion over 60 passages with
strong maintenance of pluripotency.
Results
Several hydrogel materials—such as alginate (24, 27), agarose
(28), and hyaluronic acid (29)—have been previously investi-
gated for hPSC expansion or differentiation. However, to date
thermoreversible materials have not been studied in hPSC cul-
ture, despite the fact that they offer a number of promising
features for GMP-compatible, large-scale culture. In particu-
lar, they are synthetic and defined, biocompatible, and enable
cell harvest or passaging by simply changing temperature at the
range from 4 °C to 37 °C, a mild process for cells. Also, they can be
readily processed (e.g., .into spheres or fibers) for large bioreactors.
After initial assessment of several synthesized or commercial avail-
able thermoreversible hydrogels, we found single hPSCs could
survive and retain pluripotency marker expression in 8–10%
(wt/vol) poly(N-isopropylacrylamide)-co-poly(ethylene glycol)
(PNIPAAm-PEG) hydrogel (Mebiol Gel) (SI Appendix, Fig. S1).
Preliminary investigation showed that cell behavior in this
material was significantly affected by multiple factors, including
the addition of an inhibitor for the RhoA GTPase signaling ef-
fector Rho kinase (ROCK) (30), extent of cell dissociation, the
culture medium (3), and initial seeding density. We therefore
conducted a multifactorial analysis to assess the promise of this
material relative to other materials or to cell-only suspensions,
identify the optimal conditions under which it supports the bi-
ology and culture of hPSC, and study the potential interactions
among numerous parameters. Thirty-six combinations of various
factors, including seeding with single cells or clusters; use of
ROCK inhibitor (RI); cell seeding density; culture medium; and
with or without PNIPAAm-PEG hydrogel scaffold, were tested
(Figs. 1 and 2). Specifically, cell dissociation promotes hPSC
apoptosis via Rho GTPase signaling (14, 31, 32); however, single-
cell seeding enables more reproducible expansion during large-
scale hPSC production. hPSCs were thus dissociated into single
cells and either directly encapsulated into the hydrogel (termed
single-cell seeding) or—based on the poor viability observed for
single-cell dissociation in 2D (30)—first cultured in suspension
overnight to form small clusters that were subsequently encap-
sulated in the gel (termed precluster seeding) (Fig. 1A). Also,
addition of RI for the first 24 h has been shown to support
growth of single hPSCs in liquid suspension culture (19), and we
included RI for the whole culture period (4-d RI) to assess its
effects on cell expansion. Additionally, low seeding density (∼1–
2.5 × 105 cells/mL) is often used (SI Appendix, Table S1), and we
also included medium and high seeding densities (1.0 × 106 and
2.5 × 106 cells/mL, respectively). Furthermore, two media were
used [mTeSR and completely defined Essential 8 (E8)]. More-
over, hPSC suspension in static liquid medium was also included
for comparison with the hydrogel. Finally, iPS–mesenchymal
stem cells (MSCs), an iPSC derived from human MSCs (33),
were used in this optimization.
The study revealed that (i) the hydrogel promoted high ex-
pansion rates and prevented cell agglomeration (Figs. 1B and
2A). Culturing single hPSCs in 10% (wt/vol) PNIPAAm-PEG
with E8 in the presence of RI led to the formation of dense,
uniform, and small spheroids with ∼8-, 10-, or 4.4-fold expansion
over 4 d at low, medium, or high seeding density, respectively.
However, adding RI for 1 d was insufficient to support single
cells (Figs. 1B and 2A). When using mTeSR rather than E8, only
moderate (<1.6-fold) or no expansion was reached with 4-d or
1-d RI, respectively, for all of the seeding densities, indicating
a negative interaction between mTeSR and the hydrogel scaffold
(Figs. 1B and 2A). (ii) In the hydrogel and E8, preclustered
hPSCs behaved similarly to single hPSCs. However, in the
hydrogel and mTeSR with 4-d RI, preclustered hPSCs displayed
significantly higher expansion (∼4.5-, 4.5-, 2.1-fold for low, me-
dium, high density, respectively) than single hPSCs (Figs. 1B and
2B), indicating that mTeSR stresses single cells. (iii) For all
static-suspension cultures in liquid medium without hydrogel,
large cell aggregates were found, and only ∼2.8-, 1.6-, or 0.2-fold
expansion was achieved for low, medium, or high seeding density,
respectively (Figs. 1B and 2C). Agglomeration and low expansion
(<2.0-fold) were also found in a large dynamic suspension culture
(a spinner flask) without hydrogel scaffold (SI Appendix, Fig. S2).
No significant difference was found between using mTeSR and E8
or between with 1-d or 4-d RI for these static-suspension cultures
(Figs. 1B and 2C). In summary, a combination of 10% (wt/vol)
PNIPAAm-PEG, 4-d RI, defined E8, medium seeding density
via single-cell or precluster seeding resulted in a high, 10.0-fold
cell expansion in a single 4-d passage (Fig. 1 B and C). Final, fine-
tuning of conditions revealed that 48 h RI was sufficient to support
this expansion for precluster seeding, 4-d RI was required for
single-cell seeding, and 8% (wt/vol) hydrogel performed as well as
10% (wt/vol) hydrogel (SI Appendix, Fig. S3).
We also assessed whether other, nonthermoreversible mate-
rials systems—including UV cross-linked hyarulonic acid (29),
agarose (28), and alginate hydrogel (24)—could support high
level hPSC expansion. We generated and used these materials as
described previously, in conjunction with E8 and RI. For single-
seeded iPS-MSCs, moderate expansion (∼2.8-fold) was seen only
in alginate hydrogel with medium seeding density. A slightly
higher, ∼5- or 6.5-fold expansion was achieved in agarose or
alginate hydrogel for preclustered iPS-MSCs, respectively (SI
Appendix, Fig. S4), although these numbers do not approach the
levels of expansion observed with the thermoreversible material.
The multifactorial optimization thus resulted in an effective,
completely defined system for hPSC culture, which was then
characterized in greater detail. For both single-cell and cluster
seeding, live/dead staining revealed very high viability within the
hydrogel or spheroids (Fig. 3A). Also, 5-ethynyl-2′-deoxyuridine
(EdU) staining showed uniform cell proliferation across sphe-
roids, suggesting effective transport of nutrients, oxygen, and/or
protein factors within the hydrogel and spheroids (Fig. 3B).
Microscopy also revealed that single-seeded cells expanded and
grew into spheroids with a narrow size distribution (e.g., 40–120
μm in diameter at day 5, Fig. 3C), whereas precluster seeding
resulted in spheroids with larger sizes and broader distribution
(50–300 μm in diameter at day 5, Fig. 3C). For both seeding
methods, 10-, 20-, or 21-fold expansion, with final yields of ∼1,
2.0, or 2.1 × 107 cells per mL hydrogel, was achieved for hPSCs
on day 4, 5, or 6 of the culture, respectively (Fig. 3D). Further-
more, immunostaining showed 95% of cells expressed pluri-
potency markers octamer-binding transcription factor 4 (Oct4)
and Nanog, and alkaline phosphatase expression was both high
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and homogeneous across spheroids (Fig. 3 E–G). An additional
13-d culture was conducted to explore the sensitivity of cellular
growth and pluripotency to spheroid size in this system. Single
iPS-MSCs were cultured in PNIPAAm-PEG hydrogel with E8
and RI for 13 d without passaging. An extremely low density (1.0 ×
105 cells per mL) was used to provide sufficient space for cell
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growth during the long 13-d culture. iPS-MSCs grew into sphe-
roids with mean diameter of ∼350 μm, with the larger spheroids
reached diameter up to ∼750 μm. Consistent cell growth and
pluripotent marker expression were also seen in this size range
(SI Appendix, Fig. S5). In summary, the culture system efficiently
expanded hPSCs with high quality and density.
We next assessed the generality of this system for the long-
term expansion of multiple hPSC lines (1, 33), which were con-
tinuously propagated for up to 60 passages or ∼280 d (with
passaging every 4 or 5 d). During each of these passages, iPS-
MSCs, iPS-Fib2 iPSCs, and H9 hESCs expanded ∼10- or 20-fold
over 4 or 5 d, respectively, and H1 hESCs expanded 7-fold over
4 d, indicating some differences in growth rates among the lines
(Fig. 4A). However, during this long-term culture with an ac-
cumulated expansion up to ∼1072-fold, ∼95% of cells remained
Oct4+ (Fig. 4B). Immunostaining again revealed uniform Nanog
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Fig. 2. Phase contrast images showing the cell morphologies for the factorial-designed experiment. iPS-MSCs were cultured in 10% PNIPAAm-PEG hydrogel
via single cell (A) or precluster seeding (B) or in static liquid medium without hydrogel (static suspension) (C) for 4 days in mTeSR or E8 with 1d or 4d RI at low,
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and Oct4 expressions within spheroids (SI Appendix, Fig. S6). To
our knowledge, this is the highest reported level of hPSC ex-
pansion in a culture system.
To assess whether cellular proliferation rates remained con-
sistent over time, we reevaluated the growth kinetics of hPSCs
after 10 passages in the gel. Notably, the expansion rate (∼10-, 20-,
or 21-fold at days 4, 5, or 6, respectively) (SI Appendix, Fig. S7),
pluripotency marker expression, and spheroid size distribution
(SI Appendix, Fig. S7) were similar to those at passage 1 (Fig. 3).
To further establish maintenance of cell pluripotency, em-
bryoid body (EB) differentiation in vitro and teratoma forma-
tion in vivo were conducted after long-term culture within the
hydrogel. Each cell line (iPS-MSC, iPS-Fib2, H9, H1) could
undergo differentiation into the three germ layers, with expres-
sion of endodermal (HNF3β), mesodermal (αSMA), and ecto-
dermal (Nestin) markers (Fig. 5A and SI Appendix, Fig. S8).
Additionally, each hPSC line formed teratomas after 6–12 wk in
vivo, and neural rosettes and epidermis from ectoderm, cartilage
and muscle from mesoderm, and gut-like structure from endo-
derm were observed (Fig. 5B and SI Appendix, Fig. S9). In ad-
dition, hPSCs remained karyotypically normal after long-term
culture within the gel (Fig. 5C and SI Appendix, Fig. S10).
To further assess whether hydrogel culture maintained cell
behavior in 2D, after every 40 d in 3D, a passage of the hPSCs was
returned to standard 2D surfaces. Dissociated cells attached to
surfaces coated with vitronectin and grew into compact colonies
after 4 d (SI Appendix, Fig. S11 A and B), and these cells could
subsequently undergo long-term expansion on 2D and maintain
high Oct4+ levels (SI Appendix, Fig. S12). hPSCs could then be
returned to the 3D culture system for additional expansion, in-
dicating that cells can be interchanged between 2D and this 3D
system as needed. Finally, cell banking is important for down-
stream applications, and hESCs expanded within the 3D system
could be cryopreserved as single cells (SI Appendix, Fig. S11C).
Because suspension cultures are favored for large-scale pro-
duction, we also demonstrated the hydrogel could readily be
extruded into fibers (∼2 mm in diameter) with encapsulated
cells. Suspension of these fibers in 3D liquid culture resulted in
∼19.5-fold expansion within 5 d for both single-cell and cell
cluster seeding (SI Appendix, Fig. S13), yielding sufficiently high
densities of encapsulated cell mass that the hydrogel fibers were
opaque (SI Appendix, Fig. S13B). The pluripotency marker ex-
pression and spheroid size distribution (SI Appendix, Fig. S13 C
and D) were indistinguishable from cells grown in hydrogels cast
within a culture well (Fig. 3).
Biomedical applications for hPSCs entail differentiation into
specific lineages, and we thus investigated whether cells after
long-term culture in this system could then be directed into
ectodermal, endodermal, or mesodermal lineages within the
3D material (Fig. 6). First, after a 4-d expansion in E8 medium
and 9-d differentiation in neural induction medium with small
molecule SMAD inhibitors in the 3D hydrogel (10), ∼80% of
H9-derived cells became positive for the neural progenitor
markers Nestin and Pax6 (Fig. 6A). In a parallel culture, a 4-d
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expansion in E8 medium and 5-d differentiation in endoderm
induction medium (4) in the 3D hydrogel resulted in ∼95% of H9
or iPS-MSC–derived cells being positive for the endoderm pro-
genitor markers forkhead box protein A2 (FOXA2) and SOX17
(Fig. 6B). Finally, a 4-d expansion in E8 medium and 9-d differen-
tiation in cardiomyocyte induction medium (34) within the
3D hydrogel yielded beating spheroids 2 d after transfer to a fibro-
nectin-coated plate (Movie S1).
Several clinical trials have demonstrated that fetal ventral
midbrain tissue implants can alleviate motor symptoms in Par-
kinson patients under certain circumstances, although this ap-
proach is challenged by tissue supply and other considerations
(35, 36). In recent important work, Kriks et al. (10) and Kirkeby
et al. (37) developed approaches for differentiating hPSCs into
DA progenitors or neurons that could functionally integrate into
the brains of mouse, rat, and nonhuman primate models of PD.
We investigated whether the differentiation protocols—which
included both defined (Noggin, Shh, FGF8, TGFβ3) and un-
defined protein components—could be adapted to 3D culture
under defined conditions. DA induction of H9 spheroids (40–120
μm) within the hydrogel was initiated via dual SMAD inhibition,
Shh, and a GSK3β inhibitor to activate Wnt signaling (Fig. 7A).
On day 11, 81% of cells within the spheroids (∼100–300 μm)
were positive for the ventral midbrain DA progenitor markers
FOXA2 and LMX1a (Fig. 7 B–D). These matched levels ob-
tained in 2D; however, cells in 3D expanded ∼80-fold over 15 d,
resulting in 8 × 107 cells per mL of hydrogel, compared with only
an approximately ninefold expansion on 2D surface (Fig. 7D).
Finally, these DA progenitors could subsequently be cultured on
2D surfaces as described (37) for differentiation into mature TH+
DA neurons (Fig. 7E).
Discussion
Large numbers of hPSCs, or their differentiated progeny, are
needed for many biomedical applications (9). For large-scale
expansion, currently hPSCs from a cell bank are expanded into
large numbers through progressive proliferation followed by di-
rected differentiation into progenitors or mature cells. Efficient,
scalable, and GMP-compliant culture systems are required for
such processes (9). hPSC culture has made considerable prog-
ress, but current systems achieve only moderate expansion, yield,
and quality (9) (SI Appendix, Table S1). The most effective
system reported to date enabled approximately threefold to
fourfold expansion of hESCs per passage in mTeSR medium
containing 1% BSA, for a final yield of <1 × 106 cells per mL
(18) (SI Appendix, Table S1). We have developed a 3D culture
system—which combines a synthetic thermoreversible hydrogel
and defined medium with an optimized protocol involving single-
cell passaging—for simple, defined, scalable, and GMP-compliant
hESC and hiPSC expansion (Figs. 1–5) and differentiation (Figs.
6 and 7) with high yield. Long-term culture (>280 d) with high
expansion rate (20-fold over 5 d, or 6.4 × 107-fold over 1 mo, and
1072-fold over 280 d), volumetric cell yield (2 × 107 cells per mL
of hydrogel), and quality (∼95% Oct4+) were achieved (Figs. 3
and 4). Additionally, the hPSCs were able to differentiate into all
of the three germ layers after long-term culture in the 3D system
(Fig. 5 and SI Appendix, Figs. S8 and S9). Finally, the 3D system also
supported directed differentiation into neural progenitors, endo-
derm progenitors (Fig. 6), beating cardiomyocytes (Movie S1), or
midbrain dopaminergic progenitors (Fig. 7) by simply replacing
the expansion medium with the differentiation medium. This
versatile system thus combines many advantageous and impor-
tant features.
The survival and proliferation of hESCs and hiPSCs—which
both exhibit characteristics typical of epiblast-like pluripotent stem
cells (14)—depend on multiple extracellular cues. These include
soluble protein growth factors [e.g., FGF2, TGF-β, and autocrine/
paracrine cues (15)] that signal via a number of pathways to sup-
port cell survival and pluripotency factors [e.g., Nanog, Oct4, Sox2
(38–40)]. In addition, hPSCs engage in cell–matrix interactions
(31), and cell–cell contacts via cadherins are particularly important
for survival and pluripotency maintenance. Disruption of such
cell–cell contacts leads to Abr-dependent activation of RhoA (and
inactivation of Rac1), ROCK activation, and downstream acto-
myosin hyperactivation and apoptosis (14, 32). Other environ-
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mental stress, such as mechanical forces (9, 41) or apparently
redox conditions (3), can also adversely affect cell function.
Through a combination of rational and empirical investiga-
tion, this culture system based on a thermoresponsive material
apparently addresses a number of these needs. Importantly,
multifactorial investigation indicated that the system’s properties
may result from a combination of the synthetic PNIPAAm-PEG
matrix, defined medium, and optimized protocol, as any of these
elements alone yielded suboptimal outcomes (Figs. 1 and 2, and
SI Appendix, Figs. S1–S5 and S13–S15). The culture medium
provides key soluble cues (3), and the material may conceivably
concentrate autocrine/paracrine factors near cells (15). RI ame-
liorates dissociation-induced apoptosis that otherwise occurs via
cytoskeletal-associated pathways (14, 31, 32), and future inves-
tigation may elucidate whether this mechanically soft (SI Ap-
pendix, Fig. S14) thermoresponsive material may more favorably
interface with these mechanosensitive pathways relative to other
materials (14). The material also protects cells from shear-induced
stress, yet this readily deformable hydrogel may more favorably
allow single-cell division and subsequent cluster growth relative to
chemically cross-linked hyaluronic acid, ionically associated algi-
nate, or stiff agarose hydrogels. Finally, E8 unlike mTeSR lacks
β-mercaptoethanol, an apparent stressor of hESCs, particularly
in suboptimal culture environments (SI Appendix, Fig. S15). A
combination of factors thus interacts to provide a permissive 3D
system that supports hPSC biology, and future investigations may
elucidate the mechanistic contributions of both biochemical and
mechanical features of this microenvironment.
A Nestin/DAPI αSMA/DAPI HNF3β/DAPI
B
neural rosette cartilage gut 
C
epidermis muscle
Fig. 5. hPSCs retained pluripotency and normal karyotype after long-term culture in the 3D hydrogel system. (A) EB differentiation in vitro. iPS-MSCs were
expanded in the 3D hydrogel for 35 passages via single-cell seeding before EB differentiation. Immunostaining for the three germ layers (ectoderm: Nestin;
mesoderm: αSMA; and endoderm: HNF3β) are shown. (B) Teratoma formation in vivo. iPS-MSCs expanded in 3D hydrogels for 35 passages via single-cell
seeding were injected into mice s.c., and teratomas formed after 6–12 wk. Structures from all three germ layers (arrows) were identified, including ectoderm:
neural rosette and epidermis; mesoderm: cartilage and muscle; and endoderm: gut-like-structure. (C) iPS-MSCs cultured in the 3D hydrogel for 35 passages via
single-cell seeding retained normal karyotypes. (Scale bars: A, 100 μm; B, 50 μm.)
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The system can also be adapted to multiple scales—from the
laboratory toward the clinic—to support research in cell re-
placement therapies, artificial tissues and organs, and/or high-
throughput drug screening/toxicity screening with hPSCs. For
instance, ∼50 mL of hydrogel would be sufficient to produce 109
cells for preclinical animal studies, and a bioreactor with ∼5 L of
hydrogel could yield >1011 cells for clinical studies. The ability to
move a single culture system through multiple scales may aid
clinical development.
Advances in developmental and stem cell biology have en-
abled the development of approaches to effectively differentiate
hPSCs into numerous additional cell types, such as neural crest
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Fig. 6. Neural and endodermal induction in the 3D hydrogel. hPSCs that had been cultured in the 3D system for 20–30 passages were used for differen-
tiation. (A) After 4 d of expansion and 9 d of dual SMAD inhibition, ∼80% of differentiated H9s were positive for neuroectodermal markers Nestin or PAX6.
The spheroids were dissociated into single cells before staining. (B) After 4 d of expansion and 3 d of endodermal induction, ∼95% of differentiated H9s or
iPS-MSCs were positive for endodermal progenitor markers FOXA2 and SOX17. (Scale bar: 100 μm.)
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cells (42), motor neurons (43), oligodendrocyte progenitors (44,
45), pancreatic progenitors (4, 46), hepatocyte-like cells (47),
retinal cells (48), and others (49, 50). Several of these processes
have even proceeded to clinical trials (51). Future work can
explore integrating these advances into this defined 3D hydrogel
culture system to aid efficient, economical, and reproducible cell
production for multiple future applications.
Methods
Maintaining hPSCs on 2D Surface. Human ESC lines H1 and H9 were obtained
fromWiCell Research Institute. iPS-MSC (33) (derived from human MSCs) and
iPS-Fib2 (33) (derived from human dermal fibroblasts) were gift from George
Q. Daley (Children’s Hospital Boston, Boston). hPSCs were cultured on six-
well plate coated with vitronectin (Invitrogen) in E8 medium (Invitrogen). Cells
were passaged every 4 d with 0.5 mM EDTA (Invitrogen). To replate hPSCs on
2D surfaces following expansion within the 3D hydrogel, hPSC spheroids were
dissociated with Accutase (Life Technologies) at 37 °C for 10 min, and cultured
on six-well plate coated with vitronectin in E8 medium (supplied with 10 μM
ROCK inhibitor, Y-27632, Selleckchem, for the first 24 h).
Expanding hPSCs in 3D Hydrogel. To transfer the culture from 2D to 3D, hPSCs
on Matrigel or vitronectin-coated tissue culture plates were incubated with
Accutase at 37 °C for 5 min and dissociated into single cells. For the single-cell
seeding method, dissociated cells were mixed with PNIPAAm-PEG (Cosmo
Bio) solution dissolved in E8 medium at 4 °C and cast on tissue culture plate,
then incubated at 37 °C for 15 min to form hydrogels before adding warm
E8 medium containing 10 μM ROCK inhibitor. For the precluster seeding
method, dissociated cells were cultured in suspension overnight in low ad-
hesion plates to form small clusters that were subsequently encapsulated
into the 3D hydrogel as mentioned above.
To passage hPSCs within 3D hydrogel, ice-cold PBS was added to the 3D
culture at day 4 or 5 to dissolve the gel. Spheroids were collected by
centrifuging at 200 × g for 3 min, incubated with Accutase at 37 °C for
10 min, and dissociated into single cells for reencapsulation as mentioned
above. The NucleoCounter NC-200 (Chemometec) was used to count cell
numbers. To prepare hydrogel fibers, a 4 °C PNIPAAm-PEG solution con-
taining cells was extruded into room temperature E8 medium through
a 2-mm-diameter tube. The resulting hydrogel fibers were cultured in sus-
pension in E8 medium at 37 °C. Medium was changed daily for all cultures.
To measure spheroid sizes, hPSCs were released from the hydrogel, and
phase images were taken. The diameters of >2,000 spheroids were quanti-
fied with MetaXpress software (Molecular Devices). The frequency of
spheroids within a diameter range was calculated with the Excel Histogram
Plug-in. Expanded cells were cryopreserved as single cells in E8 medium with
10% (vol/vol) DMSO and 10 μM ROCK inhibitor in liquid N2.
Staining and Imaging. Cells cultured on 2D surfaces werefixedwith 4% (wt/vol)
paraformaldehyde (PFA) at room temperature for 15 min, permeabilized with
0.25%TritonX-100 for 15min, and blockedwith 5% (vol/vol) goat serum for 1 h
before incubating with primary antibodies at room temperature for 2 h. After
extensive washing, secondary antibodies in 2% (wt/vol) BSA were added
and incubated for another 1 h. Cells were washed with PBS for three times
before imaging.
To assess the pluripotency marker expression of cells expanded in 3D
hydrogels, hPSCs were dissociated into single cells with Accutase and stained in
suspension. Cells were then placed in 96-well plates and analyzed with an
ImageXpress (Molecular Devices). The percentage of Oct4+ or Nanog+ nuclei
was quantifiedwithMetaXpress software (Molecular Devices). This process was
used to quantify the PAX6+ and Nestin+ cells after neural induction as well.
To stain spheroids, hPSCs were fixed with 4% (wt/vol) PFA at room temper-
ature for 30min, and then incubatedwith PBS plus 0.25% Triton X-100 plus 5%
(vol/vol) goat serum plus primary antibodies at 4 °C for 48 h. After extensive
washing, secondary antibodies in 2% (wt/vol) BSAwere added and incubated at
4 °C for 4 h. Cellswerewashedwith PBS for three times before imaging. Staining
without primary antibodies was used as controls for all of the immunostainings.
LIVE/DEAD Cell Viability staining (Invitrogen) was used to assess live and
dead cells, the Click-iT EdU Alexa Fluor 594 Imaging Kit (Invitrogen) was used
to label proliferating cells, and an Alkaline Phosphatase Live Stain (Invi-
trogen) was used to image alkaline phosphatase.
EB Differentiation. hPSCs were suspended in DMEMplus 20% (vol/vol) FBS plus
10 μM β-mercaptoethanol in low adhesion plates for 6 d. The EBs were then
transferred onto plates coated with 0.1% gelatin and cultured in the same
medium for another 6 d, followed by fixation and staining as above.
Teratoma Formation in Vivo. All animal protocols were approved by the
Animal Care and Use Committee of the University of California, Berkeley. A
total of 3 × 106 hPSCs was suspended in 25 μL of PBS plus 25 μL of Matrigel
(BD Biosciences) and injected s.c. at the back of the neck of the SCID Beige
mice (Charles River Laboratory), and teratomas were harvested when sizes
reached 2 cm. The tissue was then fixed with 4% (wt/vol) PFA for 48 h,
dehydrated with 70%, 95%, and 100% (vol/vol) ethanol sequentially, and
defatted with xylene for 2 h before embedding in paraffin. The 10-μm-
thick sections were cut and stained with hematoxylin and eosin.
Karyotype. Kyarotyping was performed by Oakland Children’s Hospital
Cytogenetics Laboratory.
Neural Induction (52). Following expansion, hPSCs were cultured in knockout
serum replacement (KSR) medium with 10 μM SB431542 (Selleckchem) and
100 nM LDN193189 (Selleckchem) for 5 d. Starting at day 5, the KSR medium
was gradually replaced by the N2 medium, and cells were harvested at day 9.
KSR medium was as follows: DMEM plus 15% (vol/vol) KSR plus 2 mM glu-
tamine plus 10 μM β-mercaptoethanol. N2 medium was as follows: Neuro-
basal plus N2 plus B27 (without retinoic acid) plus 2 mM L-glutamine.
Endodermal Induction (4). Following expansion, hPSCs were cultured in RPMI
1640 (Sigma) plus 0.2% FBS plus 100 ng/mL Activin-A (Peprotech) plus 20 ng/
mL Wnt3a (R&D) for 1 d and in RPMI 1640 plus 0.5% FBS plus 100 ng/mL
Activin-A for 2 more days before being fixed and immunostained.
Cardiomyocyte Differentiation (34). Following expansion, hPSCs were cultured
in RPMI 1640 plus B27 without insulin between day 0 and 7, and in RPMI 1640
plus B27 after. The following small molecules were added: 12 μM CHIR99021
(Selleckchem) for days 0–1; 5 μM IWP-2 Inhibitor (Selleckchem) for days 3–5.
Spheroids were released on day 9 to fibronectin-coated plate. Beating car-
diomyocytes were filmed on day 11.
Differentiating hPSCs into Dopaminergic Neuronal Progenitors. hPSCs were
cultured in 50% DMEM/F12 plus 50% (vol/vol) Neurobasal medium (with
1:100 N2 and 1:50 B27) for 11 d following expansion (37). The following
proteins and small molecules were added: 10 μM SB431542; 200 ng/mL
Noggin (R&D) or (100 nM LDN193189); 0.7 μM CHIR99021 and 200 ng/mL
SHH C25II. Cells were harvested at day 11.
Statistical Analysis. Statistical analyses were done using the statistical package
Instat (GraphPad Software). For multiple comparisons, themeans of triplicate
samples were compared using the Tukey multiple-comparisons analysis with
the α level indicated in the figure legend.
Antibodies. Oct4 (Santa Cruz Biotechnology; 1:100), Nanog (Santa Cruz Bio-
technology; 1:100), Nestin (Millipore; 1:200), αSMA (Abcam; 1:200), FOXA2/
HNF3β (Santa Cruz Biotechnology; 1:200), PAX6 (Covance; 1:200), LMX1a
(Millipore; 1:1,000), MAP2 (BD Biosciences; 1:1,000), TH (Pel-Freez; 1:1,000),
and SOX17 (R&D; 1:500).
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cultured in 8% or 10% hydrogels (1x106 cells/ml hydrogel) via single cell (A and B, 4-day
culture) or precluster (C and D, 5-day culture) seeding in the presence of ROCK inhibitor
(RI) for 1, 2, 4, or 5 days. The spheroid morphology (A, C), fold of expansion, and % of
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Oct4+ and Nanog+ cells (B, D) on day 4 (A, B) or 5 (C, D) are shown. Spheroids were
released from 3D hydrogels before imaging. *** indicates statistical significance at a level
of p<0.001. Scale bar: 250 µm
2% HA 2% HA
Live dead
2.5x105 cells/ml, single 1.0x106 cells/ml, single 1.0x106 cells/ml, precluster
2% HA
1% agarose 1% agarose 1% agarose
1.1% alginate 1.1% alginate 1.1% alginate
10% PNIPAAm-PEG 10% PNIPAAm-PEG 10% PNIPAAm-PEG
10.00
12.00
14.00
E
xp
an
si
on
2.5x10^5, single
1.0x10^6, single
1.0x10^6, precluster
***
***
***
0.00
2.00
4.00
6.00
8.00
HA Agarose Alginate PNIPAAm-PEG
Fo
ld
 E
xp
an
si
on
***
***
Figure S4. Culturing iPS-MSCs in various hydrogels with E8 and RI at low or medium seeding
density via single or precluster seeding. Acrylated hyaluronic acids (60 kDa) were UV crosslinked
in the presence of 0.05% Irgacure 2959 in PBS with cells (PNAS, 2007, 11298). Low melting
agarose (Sigma) was used for preparing the 1% agarose hydrogel (Cytotechnology, 2011, 227).
Alginate (Sigma) solution in HEPES buffer was extruded into 100 mM CaCl2 solution to prepare the
alginate hydrogels (PloS One, 2011, e23212). Cells were cultured for 4 days in E8 + RI and live
dead cell staining was done to evaluate the cell viability. For single cells, moderate expansion
(~2.8-fold) was observed only in alginate hydrogel with medium seeding density. Using
preclustered cells, ~5 or 6.5-fold expansion was achieved in agarose or alginate hydrogel, not as
high as the 10-fold expansion achieved with the thermoreversible PNIPAAm-PEG hydrogel. ***
indicates statistical significance at a level of p<0.001. Scale bar: 250 µm
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Figure S5. A 13-day culture of iPS-MSCs in 3D PNIPAAm-PEG hydrogel. Single iPS-
MSCs were seeded at low density (1.0x105 cells/ml) to provide sufficient space for cell
growth during the 13-day culture. Cells grew into spheroids with mean diameter of ~350
50.0
0.0 100.0 200.0 300.0 400.0
Spheroid Diameter (µm)
µm, with larger spheroids reaching diameter of ~750 µm on day 13. Consistent cell
growth and Oct4 expression were seen over the 13-day culture or diameter range. (A)
Phase images. (B and C) Fold expansion and % of Oct4+ cells over spheroid diameter.
Scale bar: 250 µm
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Figure S6. Expression of pluripotent markers Nanog and Oct4 in spheroids. H9s, iPS-
MSCs, H1s and iPS-Fib2s were cultured in PNIPAAm-PEG hydrogel with E8 medium via
single cell seeding for 60, 60, 20 and 35 passages before immunostaining. Uniform
expression of both markers were seen among spheroids. Scale bar: 100 µm
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Figure S7. The expansion fold, yield (cells/ml hydrogel), % of Oct4+ cells and spheroid
size distribution of iPS-MSCs (A) and H9s (B) on a 6-day culture at passage 10 in 3D
hydrogel. *** indicates statistical significance at a level of p<0.001
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Figure S8. EB differentiation. Immunostaining for the 3 germ layers (ectoderm: Nestin;
mesoderm: αSMA and endoderm: HNF3β). hPSCs were long term cultured in 3D
PNIPAAm-PEG hydrogel via single cell or precluster seeding before differentiation via EB.
“Single, P10” indicates 10 passages via single seeding in 3D hydrogel before EB. Scale bar:
100 µm
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Figure S9. Teratoma formation in vivo. hPSCs expanded in 3D PNIPAAm-PEG hydrogel for
iPS-hFib2, P35, single
long term were injected into mice subcutaneously. Teratomas formed after 6-12 weeks.
Structures (arrows) from all 3 germ layers were identified, including ectoderm: neural rosette
and epidermis; mesoderm: cartilage and muscle; and endoderm: gut-like-structure. “Single,
P10” indicates 10 passages via single seeding in 3D hydrogel before teratoma assary. Scale
bar: 50 µm
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Figure S10. (continued)
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Figure S10. Karyotyping for long term cultured hPSCs. “H1, P10, single” indicates H1s
were cultured in the 3D PNIPAAm-PEG gel for 10 passages via single cell seeding before
karyotyping
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Figure S11. Phase contrast images or Oct4 staining for iPS-MSC (A) or H9 (B) cells
expanding on 2D surfaces coated with vitronectin for 1 or 4 days. iPS-MSCs and H9s
were cultured in the 3D PNIPAAm-PEG hydrogel for 10 passages before being replated on
the 2D surface. (C) Oct4 staining of H9s at day 4 on 2D surface coated with vitronectin.
H9s were expanded in 3D hydrogel for 10 passages via single cell or precluster seeding
and cryopreserved in liquid N2 for 1 month before replating on 2D surfaces. Scale bar:
100 µm
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Figure S12. Oct4 staining for iPS-MSC, H9, and H1 cells cultured on 2D surfaces
coated with vitronectin for 4 days. hPSCs were cultured in the 3D hydrogel for 10
passages via single cell or precluster seeding, then replated on 2D surface for another
10 passages before staining. Scale bar: 100 µm
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Figure S13. Suspension culture of hydrogel fibers with iPS-MSCs. PNlPAAm-PEG solutions
with iPS-MSCs via single cell or precluster seeding were extruded into fibers and suspended
in medium. (A) The hydrogel fibers (dashed lines highlight the fiber edges) with spheroids at
day 3, 4, and 5 are shown, as well as spheroids harvested on day 5. (B) The fibers with cells
on day 5 appeared white. The expansion rates (C) and Oct4 expression (D) for both seeding
methods after 5 days culture were quantified. Scale bar: (A) 250 µm and (B) 2 mm
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Figure S14. The storage modulus (G’) of PNlPAAm-PEG, alginate, agrose and HA hydrogel
in PBS at 37°C. *** indicates statistical significance at a level of p<0.001
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Figure S15. Culturing iPS-MSCs in PNIPAAm-PEG hydrogel with E8 + 1% BSA + 100
µM β-mercaptoethanol. Single iPS-MSCs were encapsulated at low, medium or high
density and cultured with 1d or 4d RI. (A) Phase images on day 4. No spheroids were
formed. (B) A comparison on cell expansion under E8, mTeSR and E8 plus BSA and β-
ME. Low expansions were seen in mTeSR and E8 plus BSA and β-ME. *** indicates
statistical significance at a level of p<0.001. Scale bar: 250 µm
Table S1: Comparison of 3D culture systems in the literature and the new 3D culture system (1) 
Culture Method Cell Lines Medium Seeding Method Serial 
Expansion 
(# of 
passages) 
Yield 
(cells/ml) 
Fold of 
Expansion 
Fold of 
Expansion in  
30 days(i) 
Cell Quality  Differentiation 
Following Expansion? 
Ref 
 
(a) Suspension Culture of Cell Aggregates: 
hPSC aggregates in spinner flask  hES2, 
hES3, 
ESI049  
mTeSR Single cells 
via TrypLE 
3-5 
 
~1x106  2x/7days  Cells started to 
differentiate after 5 
passages 
 
No (2) 
hPSC aggregates in TCP hES2, 
MF12,  
iPS  
mTeSR Single cells 
via 
Collagenase 
17 
 
1-2x105  4-6x/4days 
(ii) 
~1.7x105  No (3, 4) 
EBs in spinner flask H1,  
H9  
 
KSR  No 2-3x105  15x/21days   5-6% converted to 
hematopoietic 
progenitor after 14 
days 
(5) 
EBs in STLV bioreactor H9.2  FBS  No 35x106 70x/28days ~70   (6) 
EBs in STLV bioreactor with 
perfusion and dialysis 
VUB01, 
H9, 
HUES-9  
KSR   No     EB formation and 
Neural differentiation 
(7) 
EBs in: 
     STLV bioreactor 
     Spinner flask with ball 
impeller 
     Spinner flask with paddle 
impeller 
      
1.2x/10days 
6.4x/10days 
 
2.2x/10days 
 
 
  (8) 
hPSC aggregates in 125ml 
spinner flask 
I3,  
I4,  
I6,  
H9.2  
KSR  Small clumps 
via 
mechanical 
dissociation 
20  
 
9x105  25x/10days ~1.6x104   (9, 
10) 
hPSC aggregates in 125ml 
spinner flask 
H9  
 
mTeSR, 
rapamycin 
Single cells 
via accutase   
3 4.5x105  1:5 
spit/6days 
 >90% Oct4+  (11) 
EBs in  
Spinner flask 
Stirred tank with 21% O2 
Stirred tank with 4% O2 
H9  
 
KSR, 
FBS 
 No Day16 
2.2x105 
4.0x105 
5.2x105 
 
    
23.7% 
48.3% 
48.3% converted to 
cardiomyocytes after 
16 days 
(12) 
hPSC aggregates in TCP HES1, 
HES2, 
H7 
 
KSR Small clumps 
via 
mechanical 
dissociation 
10 
 
 <5x/7days 
~100x/5wee
ks 
~980 HES1 showed 
abnormal karyotype at 
Passage 20 
 (13) 
hPSC aggregates in spinner flask H9,  
H1,  
HES2   
mTeSR(iii), 
StemPro(iii
) 
Single cells 
via accutase 
21 
 
<1x106 4.1x/4days 
3.8x/4days 
3.2x/4days 
~4.0x104  
~2.2x104  
~6.1x103  
Passaging  had to be 
done on or before 4th 
day to avoid 
differentiation 
~27.5% converted to 
cardiomyocyte on 
Day 19 
 
(14) 
           
 
(b) Suspension Culture of Cells on Microcarriers 
Matrigel coated CytodexTM3 in 
   Spinner flask, uncontrolled 
   Spinner flask, 5% air saturated 
   Spinner flask, 30% air 
saturated 
SCEDTM4
61 
 
MEF-CM   
No 
 
1.2x106 
2.2x106 
0.8x106 
 
6x/11day 
15x/11day 
7x/12day 
 
 
Severe  agglomeration   (15) 
In spinner flask on 
   DE53 coated with Matrigel 
   DE53 coated with laminin 
 
HES2, 
HES3  
MEF-CM Mechanical 
dissociation 
10  
 
 
1.43x106 
1.37x106 
 
10-15x/7day 
10-15x/7day 
 
~5.1x104 
a) 
84% Tra-1-60+ 
74% Tra-1-60+ 
b) agglomeration seen 
 (16) 
Collagen coated CytodexTM3 in 
spinner flask 
 MEF-CM  No 1.5x106 
 
6.8x/14days  a) 76% Oct4+ 
b) agglomeration seen 
 (17) 
Polystyrene beads in spinner 
flask 
  Laminin coated 
  Vitronection coated 
 StemPro  20 
 
 
1.5x106 
1.4x106 
 
8.5x/7day 
8.5x/7day 
~9.7x103 90% Oct4+   
Laminin coated beads in spinner 
flask 
H1,  
HES3 
  No 2.14x105   20% converted to 
cardiomyocytes on day 
16 
 (18) 
Matrigel coated CytodexTM3 in 
TCP 
H1,  
H9 
 
MEF-CM Single cells 
via trypsin 
11 
 
   a) seeding efficiency 
was very low 
a) agglomeration seen 
 (19) 
Matrigel coated beads in spinner 
flask 
HES2,  
HES3 
 
mTeSR, 
StemPro 
TrypLE + 
mechanical 
dissociation 
6 month  5.8x/5day ~3.8x104 a) agglomeration seen  (20) 
Matrigel coated polystyrene 
beads in spinner flask 
H1,  
H9  
 
CM  No 1x106 34-
45x/8days 
 >80% converted to 
definitive endoderm        
 (21) 
Trimethylammonium coated 
polystyrene bead in TCP 
ESI-017  CM Collagenase + 
mechanical 
dissociation 
No 2x105 2.5x/5days ~250   (22) 
Cultisphere S in spinner flask SHEF3 
 
KSR, 
CM 
 1 3.5x106 10x/7days    (23) 
 
(c) Suspension Culture of Cells in Alginate Microencapsulation 
hESCs on microcarriers in 1.1% 
alginate microbeads 
SCEDTM4
61 
 
MEF-CM  No 2.8x106 20x/20days    (24) 
hESCs in PLL-coated liquid core 
microcapsules in static and 
spinner flask 
H9 
 
KSR, 
MEF-CM, 
FBS 
 No 1.6x105 9x/15days    (25) 
hESC clusters in 1.1% calcium 
alginate microbeads in static 
culture 
       Efficient proliferation 
and maintenance of 
undifferentiated status 
for 260 days  
 (26) 
           
 
 
(d) The new culture system introduced in the paperd 
hPSCs in 3D thermoreversible 
hydrogel 
iPS-MSC, 
iPS-Fib2, 
H9,  
H1 
E8 Single cells 
via Accutase 
>60 
 
~2.0x107 10x/4days 
20x/5days 
 
 
6.4x107 ~95% Oct4+ >80% converted to 
neural lineages 
 
 
  
Advantages 
 
Disadvantages 
(a) Suspension culture of cell    
     aggregates 
 Scalable 
 Easy handling 
 Reproducible 
 Good 3D cell-cell, cell-matrix interaction 
 Difficult to control aggregate size 
 Difficult to control cell purity 
 Shear-force-induced cell death 
 Relatively low expansion rate 
 Relatively low cell yield (cells/volume) 
(b) Suspension culture of cells  
     on microcarriers 
 Scalable 
 Reproducible 
 Good mass and gas diffusion 
 Severe agglomeration of microcarriers and cells 
 Shear-force-induced cell death 
 Relatively low expansion rate 
 Relatively low cell yield 
 The processes of coating bead, seeding cells, harvesting cells and 
separating beads from cells are time-consuming and cost ineffective 
(c) Suspension culture of cells in  
     alginate microencapsulation 
 Scalable 
 Reproducible 
 Protection from shear force 
 Prevents agglomeration of cells 
 Good 3D cell-cell, cell-matrix interaction 
 Ineffective mass and gas transport within the alginate hydrogel 
 Low expansion rate 
 Low cell yield 
 The processes of encapsulation and decapsulation (w / EDTA) are time-
consuming and cost ineffective 
(d) The new 3D culture system  
     in the paper 
 Scalable 
 GMP compliant 
 Easy handling (hydrogel forms at room temperature and 
becomes solution at 4ºC) 
 Protection from shear force 
 Prevents agglomeration of cells 
 High expansion rate 
 High cell yield 
 Effective mass and gas transport 
 Good 3D cell-cell, cell-matrix interaction 
 Compatible with many types of bioreactor 
 
 
Abbreviations: CM, conditioned medium; MEF-CM, mouse embryonic fibroblast conditioned medium; KSR, knockout serum replacement; FBS, fetal bovine serum; TCP, tissue culture plate; STLV, 
slowly turning lateral vessel; EB, embryonic body; hPSC, human pluripotent stem cell 
(i) if serial expansion was demonstrated in the paper, the theoretical Fold of Expansion in 30 days was calculated as: (Fold of Expansion per passage) ^ (30)/(days per passage) 
(ii)  For these with a range instead of an accurate number, the median was taken for the calculation 
(iii) mTeSR1 and StemPro medium contain 1% and 2% BSA respectively. 
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Movie S1. H9s cultured for 20–30 passages in the 3D system were used for the cardiomyocytes differentiation. Single H9s were cultured in the hydrogel for 4 d
before differentiation. On day 9, spheroids were released from the gel and plated on fibronectin-coated plate. The movie was taken at day 11. (Scale bar: 250 μm.)
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